Cáncer de próstata resistente a la castración. Recomendaciones de consenso de la Asociación Española de Urología

Saved in:
Bibliographic Details
Published inActas urologicas españolas Vol. 41; no. 3; pp. 141 - 145
Main Authors Loizaga-Iriarte, A, Rodriguez-Antolin, A, Miñana, B, Lacasa-Viscasillas, I, Senarriaga-Ruiz de la Illa, N, Cozar-Olmo, J.M, Unda-Urzaiz, M
Format Journal Article
LanguageSpanish
Published Elsevier España, S.L.U 01.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
Author Miñana, B
Lacasa-Viscasillas, I
Loizaga-Iriarte, A
Senarriaga-Ruiz de la Illa, N
Cozar-Olmo, J.M
Rodriguez-Antolin, A
Unda-Urzaiz, M
Author_xml – sequence: 1
  fullname: Loizaga-Iriarte, A
– sequence: 2
  fullname: Rodriguez-Antolin, A
– sequence: 3
  fullname: Miñana, B
– sequence: 4
  fullname: Lacasa-Viscasillas, I
– sequence: 5
  fullname: Senarriaga-Ruiz de la Illa, N
– sequence: 6
  fullname: Cozar-Olmo, J.M
– sequence: 7
  fullname: Unda-Urzaiz, M
BookMark eNqFkUtqHDEQQEWwIePPCbLpC3S7pP5JixiGYZwYDIbEXguNujpo0pYGVc-Aj5MDeBF8hL5Y1B6vsvGqqqR6ovTqjJ344JGxLxwKDry52hbG7mMoRCoKUAUA_8QWvFEqb5WEE7YAwSGvJDSf2RnRFkBUpWwX7LCa_niLMesw28XplUYzmiwiORrRj5iZbDCZNTRGY9306ovsB9rwhL5LdZqCZtIGT-gpzHlqX1Kw7tierWlnpr8hnaa7xxiG8Gt6MRfstDcD4eV7PGePN-uH1ff87v7b7Wp5l1tRw5hXva0k8q5r5UbWZQNKtFj1IKGVooROVjWirKBWgvccUIHYcCtEXye-3vDynJXHd20MRBF7vYvuycRnzUHP6vRWv6nTszoNSid1ifp6pDCNdnAYNVmHSVPnItpRd8F9wF__x9vBeWfN8BufkbZhH336teaahAb9c17OvBvelIkGVf4Da0eTjQ
Cites_doi 10.1016/S0140-6736(10)62344-6
10.1016/S0025-7753(03)73601-X
10.1111/j.1464-410X.2010.09638.x
10.1200/JCO.2007.12.4487
10.1016/S0094-0143(05)70070-7
10.1016/j.ejca.2008.10.026
10.1200/JCO.2005.01.529
10.1007/s00256-014-1903-9
10.1200/JCO.2015.64.2702
10.1016/j.eururo.2014.07.028
ContentType Journal Article
Copyright AEU
2016 AEU
Copyright_xml – notice: AEU
– notice: 2016 AEU
DBID AAYXX
CITATION
DOI 10.1016/j.acuro.2016.09.001
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Castrate resistant prostate cancer. Consensus recommendations of the Spanish Association of Urology
EISSN 1699-7980
EndPage 145
ExternalDocumentID 10_1016_j_acuro_2016_09_001
S0210480616301309
1_s2_0_S0210480616301309
GroupedDBID 0R
2WC
457
53G
5GY
65R
6J9
77F
AACTN
AAEDT
AALRI
AAQXK
AAXUO
ABXHO
ACGFS
ADACO
ADBBV
ADCUG
AENEX
AEVXI
AFTJW
ALMA_UNASSIGNED_HOLDINGS
APOWU
ASPBG
AVWKF
AZFZN
BAWUL
C1A
DIK
E3Z
EBS
EJD
F5P
FDB
FEDTE
FGOYB
FIRID
GX1
HVGLF
HZ
IPNFZ
O9-
OK1
P2P
R2-
RIG
RSK
SCD
SES
TR2
XSB
Z7D
0R~
ABJNI
ADMUD
HZ~
AAYXX
AMRAJ
CITATION
ID FETCH-LOGICAL-c250t-4fc48e1dd78b85360927e4f08078230d845ee8405921f10e902b1c22f5c255b13
ISSN 0210-4806
IngestDate Fri Aug 23 03:55:49 EDT 2024
Fri Feb 23 02:21:30 EST 2024
Thu Aug 18 17:28:12 EDT 2022
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language Spanish
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c250t-4fc48e1dd78b85360927e4f08078230d845ee8405921f10e902b1c22f5c255b13
OpenAccessLink https://medes.com/publication/119699
PageCount 5
ParticipantIDs crossref_primary_10_1016_j_acuro_2016_09_001
elsevier_sciencedirect_doi_10_1016_j_acuro_2016_09_001
elsevier_clinicalkeyesjournals_1_s2_0_S0210480616301309
PublicationCentury 2000
PublicationDate 2017-04-01
PublicationDateYYYYMMDD 2017-04-01
PublicationDate_xml – month: 04
  year: 2017
  text: 2017-04-01
  day: 01
PublicationDecade 2010
PublicationTitle Actas urologicas españolas
PublicationYear 2017
Publisher Elsevier España, S.L.U
Publisher_xml – name: Elsevier España, S.L.U
References EAU Guidelines 2016. [consultado 10 Abr 2016]. Disponible en
Smith, Kabbinavar, Saad, Hussain, Gittelman, Bilhartz (bib0125) 2005; 23
Nicholas, Armelle, Heather, Jia (bib0095) 2010; 106
NCCN Clinical practice guidelines in oncology: Prostate cancer. Version 2.2016. [consultado 10 Abr 2016]. Disponible en
Badia, Muriel, Gracia, Núñez-Olarte, Perulero, Gálvez (bib0115) 2003; 120
Brasso, Thomsen, Schrader, Schmid, Lo rente, Retz (bib0135) 2015; 68
Scher, Halabi, Tannock, Underwood, Wang, DePalantino (bib0105) 2008; 26
AUA castration-resistant prostate cancer guideline. [consultado 10 Abr 2016]. Disponible en
Fizazi, Carducci, Smith, Damiao, Brown, Karsh (bib0140) 2011; 377
George, Kantoff (bib0120) 1999; 26
Eisenhauer, Therasse, Bogaerts, Schwartz, Sargent, Ford (bib0130) 2009; 45
Ryan, Crawford, Shore, Borre, Zonnenberg, Beuzeboc (bib0100) 2014; 32
Scher, Morris, Stadler, Morris, Sternberg, Carducci (bib0145) 2016; 34
Shen, Deng, Hu (bib0090) 2014; 43
Scher (10.1016/j.acuro.2016.09.001_bib0145) 2016; 34
Fizazi (10.1016/j.acuro.2016.09.001_bib0140) 2011; 377
10.1016/j.acuro.2016.09.001_bib0080
Smith (10.1016/j.acuro.2016.09.001_bib0125) 2005; 23
10.1016/j.acuro.2016.09.001_bib0085
10.1016/j.acuro.2016.09.001_bib0075
George (10.1016/j.acuro.2016.09.001_bib0120) 1999; 26
Brasso (10.1016/j.acuro.2016.09.001_bib0135) 2015; 68
Nicholas (10.1016/j.acuro.2016.09.001_bib0095) 2010; 106
Shen (10.1016/j.acuro.2016.09.001_bib0090) 2014; 43
Badia (10.1016/j.acuro.2016.09.001_bib0115) 2003; 120
Ryan (10.1016/j.acuro.2016.09.001_bib0100) 2014; 32
Scher (10.1016/j.acuro.2016.09.001_bib0105) 2008; 26
Eisenhauer (10.1016/j.acuro.2016.09.001_bib0130) 2009; 45
References_xml – volume: 377
  start-page: 813
  year: 2011
  end-page: 822
  ident: bib0140
  article-title: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study
  publication-title: Lancet
  contributor:
    fullname: Karsh
– volume: 23
  start-page: 2918
  year: 2005
  end-page: 2925
  ident: bib0125
  article-title: Natural history of rising serum prostate-specific antigen in men with castrate non-metastatic prostate cancer
  publication-title: J Clin Oncol
  contributor:
    fullname: Bilhartz
– volume: 120
  start-page: 52
  year: 2003
  end-page: 59
  ident: bib0115
  article-title: Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica
  publication-title: Med Clin (Barc)
  contributor:
    fullname: Gálvez
– volume: 45
  start-page: 228
  year: 2009
  end-page: 247
  ident: bib0130
  article-title: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
  publication-title: Eur J Cancer
  contributor:
    fullname: Ford
– volume: 34
  start-page: 1402
  year: 2016
  end-page: 1418
  ident: bib0145
  article-title: Trial design and objectives for castration- resistant prostate cancer: Updated recommendations from the Prostate Cancer Clinical Trials Working Group 3
  publication-title: J Clin Oncol.
  contributor:
    fullname: Carducci
– volume: 26
  start-page: 303
  year: 1999
  end-page: 310
  ident: bib0120
  article-title: Prognostic indicators in hormone refractory prostate cancer
  publication-title: Urol Clin North Am
  contributor:
    fullname: Kantoff
– volume: 68
  start-page: 317
  year: 2015
  end-page: 324
  ident: bib0135
  article-title: Enzalutamide antitumour activity against metastatic castration-resistant prostate cancer previously treated with docetaxel and abiraterone: A multicentre analysis
  publication-title: Eur Urol
  contributor:
    fullname: Retz
– volume: 32
  start-page: 5s
  year: 2014
  ident: bib0100
  article-title: Effect of abiraterone acetate and low-dose prednisone on PSA in patients with nonmetastatic castration-resistant prostate cancer: The results from IMAAGEN core study
  publication-title: J Clin Oncol
  contributor:
    fullname: Beuzeboc
– volume: 26
  start-page: 1148
  year: 2008
  end-page: 1159
  ident: bib0105
  article-title: Design and points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
  publication-title: J Clin Oncol
  contributor:
    fullname: DePalantino
– volume: 43
  start-page: 1503
  year: 2014
  end-page: 1513
  ident: bib0090
  article-title: Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: A meta-analysis
  publication-title: Skeletal Radiol
  contributor:
    fullname: Hu
– volume: 106
  start-page: 966
  year: 2010
  end-page: 973
  ident: bib0095
  article-title: Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: A double-blind, placebo-controlled, randomized Phase II trial
  publication-title: BJU Int
  contributor:
    fullname: Jia
– volume: 377
  start-page: 813
  year: 2011
  ident: 10.1016/j.acuro.2016.09.001_bib0140
  article-title: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)62344-6
  contributor:
    fullname: Fizazi
– volume: 120
  start-page: 52
  year: 2003
  ident: 10.1016/j.acuro.2016.09.001_bib0115
  article-title: Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica
  publication-title: Med Clin (Barc)
  doi: 10.1016/S0025-7753(03)73601-X
  contributor:
    fullname: Badia
– volume: 106
  start-page: 966
  year: 2010
  ident: 10.1016/j.acuro.2016.09.001_bib0095
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2010.09638.x
  contributor:
    fullname: Nicholas
– ident: 10.1016/j.acuro.2016.09.001_bib0075
– volume: 26
  start-page: 1148
  year: 2008
  ident: 10.1016/j.acuro.2016.09.001_bib0105
  article-title: Design and points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.12.4487
  contributor:
    fullname: Scher
– ident: 10.1016/j.acuro.2016.09.001_bib0080
– volume: 26
  start-page: 303
  year: 1999
  ident: 10.1016/j.acuro.2016.09.001_bib0120
  article-title: Prognostic indicators in hormone refractory prostate cancer
  publication-title: Urol Clin North Am
  doi: 10.1016/S0094-0143(05)70070-7
  contributor:
    fullname: George
– volume: 45
  start-page: 228
  year: 2009
  ident: 10.1016/j.acuro.2016.09.001_bib0130
  article-title: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2008.10.026
  contributor:
    fullname: Eisenhauer
– volume: 32
  start-page: 5s
  issue: suppl abstr 5086
  year: 2014
  ident: 10.1016/j.acuro.2016.09.001_bib0100
  article-title: Effect of abiraterone acetate and low-dose prednisone on PSA in patients with nonmetastatic castration-resistant prostate cancer: The results from IMAAGEN core study
  publication-title: J Clin Oncol
  contributor:
    fullname: Ryan
– volume: 23
  start-page: 2918
  year: 2005
  ident: 10.1016/j.acuro.2016.09.001_bib0125
  article-title: Natural history of rising serum prostate-specific antigen in men with castrate non-metastatic prostate cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.01.529
  contributor:
    fullname: Smith
– ident: 10.1016/j.acuro.2016.09.001_bib0085
– volume: 43
  start-page: 1503
  year: 2014
  ident: 10.1016/j.acuro.2016.09.001_bib0090
  article-title: Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: A meta-analysis
  publication-title: Skeletal Radiol
  doi: 10.1007/s00256-014-1903-9
  contributor:
    fullname: Shen
– volume: 34
  start-page: 1402
  year: 2016
  ident: 10.1016/j.acuro.2016.09.001_bib0145
  article-title: Trial design and objectives for castration- resistant prostate cancer: Updated recommendations from the Prostate Cancer Clinical Trials Working Group 3
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2015.64.2702
  contributor:
    fullname: Scher
– volume: 68
  start-page: 317
  year: 2015
  ident: 10.1016/j.acuro.2016.09.001_bib0135
  article-title: Enzalutamide antitumour activity against metastatic castration-resistant prostate cancer previously treated with docetaxel and abiraterone: A multicentre analysis
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2014.07.028
  contributor:
    fullname: Brasso
SSID ssj0024387
Score 2.0220087
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 141
SubjectTerms Urology
Title Cáncer de próstata resistente a la castración. Recomendaciones de consenso de la Asociación Española de Urología
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0210480616301309
https://dx.doi.org/10.1016/j.acuro.2016.09.001
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKcuGCQIAoL-XALTiKU-d17JaFBe1yYYt6s-zEWXW1Sqsk5dB_sz9gD2h_Qs_8J2bivLRUK5ZL6_oV1_NlHvZ4TMj7SRB4XPqaYrw9ytM4oyrzFQ00SPcwSHWk8DTy6bfgeM6_LvzFaPR74LW0qZSTbPeeK_kfqkIe0BVPyd6Dsl2nkAFpoC98AoXh859oPKu3uRnQDa_5ttf1tvfhBA8JSRvsaCQhTJwt7UtpJxJXNZKlqZM7qDFi-IUU8jBgP_aQoG91Xq4wDU2mNem6JvYRsJ86zcAgxjrzAnlnPYqPcqjnTpNKlvamaFhraeth006PP1ktt_Jc0i8wWYW5qG_q9HtAabE83-gtnebVqrlYvi8-NcNi0pxqO-wKTiQ8UNIfyxK-8VIlwwid4QIHCM3eL8bwQbBKKY_cYMi0ORuAczLgwKwp0c0vf6-cMEsWF4BZmAl08AscE7i0F4utK8Atadn5MLbucRei7kRgJ8KN0UnwAXnohbGPawGfF2wQ-rG-r7H7P20QrNrd8K-R7FeUBsrP2RPyuLFarKmB4FMy0uUz8nO2u0LoWam21sXupoad1cPOktaltFrY7W5yx7oFOWzZQg7TUL2FHFS3EG67X4AXLDNQ213L52T-6ehsdkybazxoAvp1RXmW8EizNA0jBcph4MZeqHnm4k0HYACnEfe1jsBwiD2WMVfHrqdY4nmZD-19xSYvyEEOg3pJLKYgP8wU1zzmapIqlcRZBELIDz0V8nRMPrRzJtYmWou4g05jErbzKtqDyCA6ddm846VgovSEK74jzZBkYL3gVn88JkHXslFVjQoqAGF3PfLV_Ub4mjzqX4k35KAqNvotaMGVeldj6w_VF7Hh
link.rule.ids 315,786,790,27957,27958
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=C%C3%A1ncer+de+pr%C3%B3stata+resistente+a+la+castraci%C3%B3n.+Recomendaciones+de+consenso+de+la+Asociaci%C3%B3n+Espa%C3%B1ola+de+Urolog%C3%ADa&rft.jtitle=Actas+urologicas+espa%C3%B1olas&rft.au=Loizaga-Iriarte%2C+A.&rft.au=Rodriguez-Antolin%2C+A.&rft.au=Mi%C3%B1ana%2C+B.&rft.au=Lacasa-Viscasillas%2C+I.&rft.date=2017-04-01&rft.issn=0210-4806&rft.volume=41&rft.issue=3&rft.spage=141&rft.epage=145&rft_id=info:doi/10.1016%2Fj.acuro.2016.09.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_acuro_2016_09_001
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F02104806%2FS0210480617X00028%2Fcov150h.gif